Subunit vaccine · VDDBV0320
Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT04006808 | Phase 2 | Herpes Zoster |
| NCT02979639 | Phase 3 | Herpes Zoster |
| NCT02581410 | Phase 3 | Herpes Zoster |
| NCT04091451 | Phase 3 | Herpes Zoster |
| NCT01767467 | Phase 3 | Herpes Zoster |
| NCT01827839 | Phase 3 | Herpes Zoster |
| NCT00920218 | Phase 2 | Herpes Zoster |
| NCT01086449 | Phase 1 | Herpes Zoster |
| NCT02052596 | Phase 3 | Herpes Zoster |
| NCT01954251 | Phase 3 | Herpes Zoster |
| NCT02690207 | Phase 3 | Herpes Zoster |
| NCT02735915 | Phase 3 | Herpes Zoster |
| NCT01751165 | Phase 3 | Herpes Zoster |
| NCT01777321 | Phase 3 | Herpes Zoster |
| NCT02723773 | Phase 3 | Herpes Zoster |
| NCT00434577 | Phase 2 | Herpes Zoster |
| NCT01165203 | Phase 2 | Herpes Zoster |
| NCT00802464 | Phase 2 | Herpes Zoster |
| NCT01610414 | Phase 3 | Herpes Zoster |
| NCT01165177 | Phase 3 | Herpes Zoster |
| NCT02058589 | Phase 3 | Herpes Zoster |
| NCT04176939 | Phase 3 | Herpes Zoster |
| NCT03439657 | Phase 3 | Herpes Zoster; Herpes Zoster Vaccine |
| NCT01798056 | Phase 3 | Herpes Zoster; Herpes Zoster Vaccine |
| NCT02075515 | Phase 3 | Herpes Zoster; Herpes Zoster Vaccine |
| NCT02045836 | Phase 3 | Herpes Zoster; Herpes Zoster Vaccine |
| NCT01165229 | Phase 3 | Influenza; Herpes Zoster |
| NCT05082688 | Phase 2 | Kidney Transplant; Complications |
| NCT03993717 | Approved | Rheumatoid Arthritis; Healthy Controls |
| NCT03886038 | Approved | Varicella Zoster Vaccine |
| NCT03493776 | Approved | Varicella Zoster Virus Infection |
| NCT04403139 | Approved | Zoster; Zoster Varicella; Shingles; Chicken Pox |
| NCT04047979 | Phase 2 | Varicella |
| NCT05047770 | Phase 3 | Varicella |
| NCT05219253 | Phase 3 | Herpes Zoster |
| NCT04748939 | Approved | Herpes Zoster |